A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used to strengthen the evidence base of as many of our programs as possible.

Some of the greatest advances in science are unfolding now inside Amgen.

Amgen was one of the first companies to recognize the potential of modern biotechnology in developing valuable medicines for patients.

Breakaway from Cancer represents a partnership between Amgen and six nonprofit organizations dedicated to empowering patients with education, resources and hope, offering a broad range of services to people affected by cancer.

What is the impact of migraine beyond the headache?

Amgen Biosimilars are backed by our four decades of experience in the research, development, manufacturing, and supply of innovator biologics.

Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations.

The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work.

At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes.